Juvenile myelomonocytic leukemia (JMML) is a unique, aggressive hematopoietic disorder
of infancy/early childhood caused by excessive proliferation of cells of monocytic and …

Myeloid neoplasms derive from the pathological clonal expansion of an abnormal stem cell
and span a diverse spectrum of phenotypes including acute myeloid leukaemia (AML) …

In the 2008 WHO classification, chronic myeloid malignancies that share both
myelodysplastic and myeloproliferative features define the myelodysplastic …

Introduction: Allogeneic hematopoietic stem cell transplantation (SCT) is the treatment of
choice for many malignant hematological disorders. Following recent improvements in non …

Juvenile myelomonocytic leukemia (JMML) is a rare pediatric myelodysplastic/
myeloproliferative neoplasm overlap disease. JMML is associated with mutations in the RAS …

Myelodysplastic syndromes (MDS) and the mixed myelodysplastic/myeloproliferative
disorder juvenile myelomonocytic leukaemia (JMML) are rare haematopoietic stem cell …

In 1982, chronic myelomonocytic leukemia (CMML) was first classified in the category of
myelodysplastic syndromes (MDSs), but it always seemed somewhat out of place compared …

Since 2002, date of publication of the previous Italian Society of Haematology (SIE) practice
guidelines for management of myelodysplastic syndromes (MDS), novel disease-modifying …

Myelodysplastic syndrome (MDS) is a clonal bone marrow disorder, typically of older adults,
which is characterized by ineffective hematopoiesis, peripheral blood cytopenias and risk of …

Juvenile myelomonocytic leukemia is an overlapping myeloproliferative and
myelodysplastic disorder of early childhood. It is associated with a spectrum of diverse …